Demonstration of the presence of lipid peroxide-modified proteins in human atherosclerotic lesions using a novel lipid peroxide-modified anti- peptide antibody

Atherosclerosis

Volumn 143, Issue 2, 1999, Pages 335-340

  Kim, Jong G ^a   Taylor, W Robert ^a   Parthasarathy, Sampath ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Lipid peroxidation; Low density lipoprotein; Oxidized low density lipoprotein

Indexed keywords

LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY;

ANTIGENICITY; AORTA ATHEROSCLEROSIS; ARTICLE; AUTOPSY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MODIFICATION;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; AORTA; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIPID PEROXIDES; LIPOPROTEINS, LDL; LYSINE; OXIDATION-REDUCTION; PEPTIDES; PREGNANCY PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 0032949195     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00320-7     Document Type: Article

References (19)

1. Haberland M.E., Fong D., Cheng L. Malondialdehyde-altered protein occurs in the atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 241:1988;215-218.
2. Palinski W., Rosenfeld M.E., Yla Herttuala S., Gurtner G.C., Socher S.S., Butler S.W., Parthasarathy S., Carew T.E., Steinberg D., Witztum J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA. 86:1989;1372-1376.
3. Rosenfeld M.E., Palinski W., Yla Herttuala S., Butler S., Witztum J.L. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:1990;336-349.
4. Palinski W., Ord V.A., Plump A.S., Breslow J.L., Steinberg D., Witztum J.L. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb. 14:1994;605-616.
5. Holvoet P., Perez G., Zhao Z., Brouwers E., Berner H., Collen D. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest. 95:1995;2611-2619.
6. Jurgens G., Chen Q., Esterbauer H., Mair S., Ledinski G., Dinges H.P. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a). Arterioscler Thromb. 13:1993;1689-1699.
7. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J Clin Invest. 97:1996;1535-1544.
8. Boyd H.C., Gown A.M., Wolfbauer G., Chait A. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol. 135:1989;815-825.
9. Itabe H., Takeshima E., Iwasaki H., Kimura J., Yoshida Y., Imanaka T., Takano T. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. J Biol Chem. 269:1994;15274-15279.
10. Hammer A., Kager G., Dohr G., Rabl H., Ghassempur I., Jurgens G. Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins. Arterioscler Thromb Vasc Biol. 15:1995;704-713.
11. Kim J.G., Sabbagh F., Santanam N., Wilcox J.N., Medford R.M., Parthasarathy S. Generation of a polyclonal antibody against lipid peroxide-mediated proteins. Free Radic Biol Med. 23:1997;251-259.
12. Torzewski M., Klouche M., Hock J., Meßner M., Dorweiler B., Torzewski J., Gabbert H.E., Bhakdi S. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. Arterioscler Thromb Vasc Biol. 18:1998;369-378.
13. Hoff H.F., Heideman C.L., Jackson R.L., Bayardo R.J., Kim H.S., Gotto A.M. Jr. Localization patterns of plasma apolipoproteins in human atherosclerotic lesions. Circ Res. 37:1975;72-79.
14. Dell A., Morris H.R., Easton R.L., Panico M., Patankar M., Oehniger S., Koistinen R., Koistinen H., Seppala M., Clark G.F. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppresive and contraceptive activities. J Biol Chem. 270:1995;24116-24126.
15. Poddar A.S., Kim J.G., Gill K.P., Bates B.N., Santanam N., Rock J.A., Murphy A.A., Parthasarathy S. Generation and characterization of a polyclonal antipeptide antibody to human glycodelin. Fertil Steril. 69:1998;543-548.
16. Beetens J.R., Coene M.C., Verheyen A., Zonnekeyn L., Herman A.G. Influence of vitamin C on the metabolism of arachidonic acid and the development of aortic lesions during experimental atherosclerosis in rabbits. Biomed Biochim Acta. 43:1984;S273-S276.
17. Fruebis J., Parthasarathy S., Steinberg D. Evidence for a concerted reaction between lipid hydroperoxides and polypeptides. Proc Natl Acad Sci USA. 89:1992;10588-10592.
18. Parthasarathy S. Lipid peroxidation-induced protein modifications in the oxidation of low density lipoprotein. Packer L., Cadenas E. Biological oxidants and antioxidants. 1994;255-259 Hippokrates Verlag, Stuttgart.
19. Fong L.G., Parthasarathy S., Witztum J.L., Steinberg D. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J Lipid Res. 28:1987;1466-1477.